D'Amico F - Search Results

1

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, Schölmerich J, Bemelman W, Danese S, Mary JY, Rubin D, Colombel JF, Peyrin-Biroulet L, Dotan I, Abreu MT, Dignass A; International Organization for the Study of IBD. Turner D, et al. Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19. Gastroenterology. 2021. PMID: 33359090

2

Unmet Needs in IBD: the Case of Fatigue.

Hindryckx P, Laukens D, D'Amico F, Danese S. Hindryckx P, et al. Clin Rev Allergy Immunol. 2018 Dec;55(3):368-378. doi: 10.1007/s12016-017-8641-4. Clin Rev Allergy Immunol. 2018. PMID: 28852978 Review.

3

Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.

Danese S, D'Amico F, Bonovas S, Peyrin-Biroulet L. Danese S, et al. Inflamm Bowel Dis. 2018 Sep 15;24(10):2106-2112. doi: 10.1093/ibd/izy076. Inflamm Bowel Dis. 2018. PMID: 29697791 Review.

4

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials.

D'Amico F, Fiorino G, Furfaro F, Allocca M, Danese S. D'Amico F, et al. Expert Opin Investig Drugs. 2018 Jul;27(7):595-599. doi: 10.1080/13543784.2018.1492547. Epub 2018 Jul 6. Expert Opin Investig Drugs. 2018. PMID: 29938545 Review.

5

JAK inhibitors: Novel developments in management of ulcerative colitis.

Fiorino G, D'Amico F, Italia A, Gilardi D, Furfaro F, Danese S. Fiorino G, et al. Best Pract Res Clin Gastroenterol. 2018 Feb-Apr;32-33:89-93. doi: 10.1016/j.bpg.2018.05.015. Epub 2018 May 23. Best Pract Res Clin Gastroenterol. 2018. PMID: 30060943 Review.

6

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

D'Amico F, Roda G, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Curr Pharm Des. 2019;25(1):19-24. doi: 10.2174/1381612825666190307165703. Curr Pharm Des. 2019. PMID: 30848193 Review.

7

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing.

D'Amico F, Fiorino G, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Immunotherapy. 2019 May;11(7):565-575. doi: 10.2217/imt-2018-0209. Epub 2019 Mar 12. Immunotherapy. 2019. PMID: 30860423 Review.

8

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience.

D'Amico F, Parigi TL, Fiorino G, Peyrin-Biroulet L, Danese S. D'Amico F, et al. Therap Adv Gastroenterol. 2019 May 16;12:1756284819848631. doi: 10.1177/1756284819848631. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31205486 Free PMC article. Review.

9

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group.

D'Amico F, Pouillon L, Argollo M, Hart A, Fiorino G, Vegni E, Radice S, Gilardi D, Fazio M, Leone S, Bonovas S, Magro F, Danese S, Peyrin-Biroulet L. D'Amico F, et al. Dig Liver Dis. 2020 Feb;52(2):138-142. doi: 10.1016/j.dld.2019.11.004. Epub 2019 Dec 4. Dig Liver Dis. 2020. PMID: 31812570 Review.

10

Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.

Fauny M, D'Amico F, Bonovas S, Netter P, Danese S, Loeuille D, Peyrin-Biroulet L. Fauny M, et al. J Crohns Colitis. 2020 Jun 19;14(5):688-693. doi: 10.1093/ecco-jcc/jjz205. J Crohns Colitis. 2020. PMID: 31858121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

743 results

Search Page